Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1957 1
1989 1
1990 1
1992 2
1994 1
1996 3
1998 1
2001 2
2002 2
2003 3
2004 2
2005 3
2007 2
2008 4
2009 1
2010 2
2011 1
2012 3
2013 3
2014 5
2015 2
2016 2
2017 2
2018 4
2019 5
2020 6
2021 9
2022 10
2023 5
2024 5
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

91 results

Results by year

Filters applied: . Clear all
Page 1
Abiraterone and increased survival in metastatic prostate cancer.
de Bono JS, Logothetis CJ, Molina A, Fizazi K, North S, Chu L, Chi KN, Jones RJ, Goodman OB Jr, Saad F, Staffurth JN, Mainwaring P, Harland S, Flaig TW, Hutson TE, Cheng T, Patterson H, Hainsworth JD, Ryan CJ, Sternberg CN, Ellard SL, Fléchon A, Saleh M, Scholz M, Efstathiou E, Zivi A, Bianchini D, Loriot Y, Chieffo N, Kheoh T, Haqq CM, Scher HI; COU-AA-301 Investigators. de Bono JS, et al. N Engl J Med. 2011 May 26;364(21):1995-2005. doi: 10.1056/NEJMoa1014618. N Engl J Med. 2011. PMID: 21612468 Free PMC article. Clinical Trial.
Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study.
Fizazi K, Scher HI, Molina A, Logothetis CJ, Chi KN, Jones RJ, Staffurth JN, North S, Vogelzang NJ, Saad F, Mainwaring P, Harland S, Goodman OB Jr, Sternberg CN, Li JH, Kheoh T, Haqq CM, de Bono JS; COU-AA-301 Investigators. Fizazi K, et al. Lancet Oncol. 2012 Oct;13(10):983-92. doi: 10.1016/S1470-2045(12)70379-0. Epub 2012 Sep 18. Lancet Oncol. 2012. PMID: 22995653 Clinical Trial.
Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial.
Thatcher N, Hirsch FR, Luft AV, Szczesna A, Ciuleanu TE, Dediu M, Ramlau R, Galiulin RK, Bálint B, Losonczy G, Kazarnowicz A, Park K, Schumann C, Reck M, Depenbrock H, Nanda S, Kruljac-Letunic A, Kurek R, Paz-Ares L, Socinski MA; SQUIRE Investigators. Thatcher N, et al. Lancet Oncol. 2015 Jul;16(7):763-74. doi: 10.1016/S1470-2045(15)00021-2. Epub 2015 Jun 1. Lancet Oncol. 2015. PMID: 26045340 Free article. Clinical Trial.
Information scrambling in quantum circuits.
Mi X, Roushan P, Quintana C, Mandrà S, Marshall J, Neill C, Arute F, Arya K, Atalaya J, Babbush R, Bardin JC, Barends R, Basso J, Bengtsson A, Boixo S, Bourassa A, Broughton M, Buckley BB, Buell DA, Burkett B, Bushnell N, Chen Z, Chiaro B, Collins R, Courtney W, Demura S, Derk AR, Dunsworth A, Eppens D, Erickson C, Farhi E, Fowler AG, Foxen B, Gidney C, Giustina M, Gross JA, Harrigan MP, Harrington SD, Hilton J, Ho A, Hong S, Huang T, Huggins WJ, Ioffe LB, Isakov SV, Jeffrey E, Jiang Z, Jones C, Kafri D, Kelly J, Kim S, Kitaev A, Klimov PV, Korotkov AN, Kostritsa F, Landhuis D, Laptev P, Lucero E, Martin O, McClean JR, McCourt T, McEwen M, Megrant A, Miao KC, Mohseni M, Montazeri S, Mruczkiewicz W, Mutus J, Naaman O, Neeley M, Newman M, Niu MY, O'Brien TE, Opremcak A, Ostby E, Pato B, Petukhov A, Redd N, Rubin NC, Sank D, Satzinger KJ, Shvarts V, Strain D, Szalay M, Trevithick MD, Villalonga B, White T, Yao ZJ, Yeh P, Zalcman A, Neven H, Aleiner I, Kechedzhi K, Smelyanskiy V, Chen Y. Mi X, et al. Among authors: mcclean jr. Science. 2021 Dec 17;374(6574):1479-1483. doi: 10.1126/science.abg5029. Epub 2021 Oct 28. Science. 2021. PMID: 34709938
Quantum advantage in learning from experiments.
Huang HY, Broughton M, Cotler J, Chen S, Li J, Mohseni M, Neven H, Babbush R, Kueng R, Preskill J, McClean JR. Huang HY, et al. Among authors: mcclean jr. Science. 2022 Jun 10;376(6598):1182-1186. doi: 10.1126/science.abn7293. Epub 2022 Jun 9. Science. 2022. PMID: 35679419
Introducing the Neurology Milestones 2.0.
Dewey JJ, Chiota-McCollum N, Barratt D, Edgar L, Gutmann L, Shelgikar AV, Ward J, Kilgore SM; Neurology Milestones 2.0 Work Group. Dewey JJ, et al. Neurology. 2022 Mar 1;98(9):366-372. doi: 10.1212/WNL.0000000000013312. Epub 2022 Jan 11. Neurology. 2022. PMID: 35017311 No abstract available.
Rooting out racial stereotypes in Neurology®: A commentary on "Lucky and the root doctor".
Hamilton RH, McClean JC 2nd, Greicius MD, Gamaldo CE, Burrus TM, Charleston L 4th, Correa DJ, Ebong IM, Hamilton R, Lewis S, Thomas RP, Vargas A, Flippen CC 2nd. Hamilton RH, et al. Among authors: mcclean jc 2nd. Neurology. 2019 May 28;92(22):1029-1032. doi: 10.1212/WNL.0000000000007578. Epub 2019 May 3. Neurology. 2019. PMID: 31053666 No abstract available.
Inflammatory biomarkers in Alzheimer's disease plasma.
Morgan AR, Touchard S, Leckey C, O'Hagan C, Nevado-Holgado AJ; NIMA Consortium; Barkhof F, Bertram L, Blin O, Bos I, Dobricic V, Engelborghs S, Frisoni G, Frölich L, Gabel S, Johannsen P, Kettunen P, Kłoszewska I, Legido-Quigley C, Lleó A, Martinez-Lage P, Mecocci P, Meersmans K, Molinuevo JL, Peyratout G, Popp J, Richardson J, Sala I, Scheltens P, Streffer J, Soininen H, Tainta-Cuezva M, Teunissen C, Tsolaki M, Vandenberghe R, Visser PJ, Vos S, Wahlund LO, Wallin A, Westwood S, Zetterberg H, Lovestone S, Morgan BP; Annex: NIMA–Wellcome Trust Consortium for Neuroimmunology of Mood Disorders and Alzheimer's Disease. Morgan AR, et al. Alzheimers Dement. 2019 Jun;15(6):776-787. doi: 10.1016/j.jalz.2019.03.007. Epub 2019 Apr 30. Alzheimers Dement. 2019. PMID: 31047856 Free PMC article.
91 results